tm logo

Monitor this mark

View On USPTO

GENOSYL
Live/Registered
REGISTERED AND RENEWED

on 26 Aug 2024

Last Applicant/ Owned by

VERO BIOTECH INC.

387 Technology Circle NW, Suite 125

Atlanta

GA

30313

Serial Number

85981080 filed on 02th Dec 2011

Registration Number

4496333 registered on 11th Mar 2014

in the Principal Register

Correspondent Address

Marissa B. Lewis

Marissa B. Lewis Mitchell Silberberg & Knupp LLP

New York, NY 10022

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

GENOSYL

pharmaceutical preparation, namely, nitric oxide for inhalation for the diagnosis and treatment of heart, lung, brain, hematologic and thrombotic diseases

Classification Information

Class [005]
Pharmaceutical Products

pharmaceutical preparation, namely, nitric oxide for inhalation for the diagnosis and treatment of heart, lung, brain, hematologic and thrombotic diseases

First Use Date in General

29th Oct 2013

First Use Date in Commerce

29th Oct 2013

Mark Details

Serial Number

No 85981080

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 52847-00001

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
26th Aug 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
26th Aug 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
26th Aug 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
22nd Aug 2024TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
22nd Aug 2024POST REGISTRATION ACTION MAILED - SEC. 8 & 9
20th Aug 2024TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
24th May 2024POST REGISTRATION ACTION MAILED - SEC. 8 & 9
24th May 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06th Mar 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
13th Feb 2024TEAS SECTION 8 & 9 RECEIVED